Go Pro

Venture Life Group (VLG) Competitors

Venture Life Group logo
GBX 69 +0.50 (+0.73%)
As of 09/15/2026 11:53 AM Eastern

VLG vs. BXP, ANCR, BVXP, ORPH, and EAH

Should you buy Venture Life Group stock or one of its competitors? Venture Life Group's main competitors and comparable companies include Beximco Pharmaceuticals (BXP), Animalcare Group (ANCR), Bioventix (BVXP), Open Orphan (ORPH), and ECO Animal Health Group (EAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Venture Life Group compare to Beximco Pharmaceuticals?

Venture Life Group (LON:VLG) and Beximco Pharmaceuticals (LON:BXP) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

Beximco Pharmaceuticals has higher revenue and earnings than Venture Life Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.36£747.21K£4.3715.79
Beximco Pharmaceuticals£53.93B0.00£970.84B£1.94 thousand0.03

Venture Life Group has a beta of 0.234, meaning that its share price is 77% less volatile than the broader market. Comparatively, Beximco Pharmaceuticals has a beta of 0.248, meaning that its share price is 75% less volatile than the broader market.

Venture Life Group has a net margin of 17.42% compared to Beximco Pharmaceuticals' net margin of 16.76%. Beximco Pharmaceuticals' return on equity of 11.99% beat Venture Life Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
Beximco Pharmaceuticals 16.76%11.99%6.97%

In the previous week, Beximco Pharmaceuticals had 1 more articles in the media than Venture Life Group. MarketBeat recorded 2 mentions for Beximco Pharmaceuticals and 1 mentions for Venture Life Group. Venture Life Group's average media sentiment score of 1.11 beat Beximco Pharmaceuticals' score of 0.37 indicating that Venture Life Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Venture Life Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Beximco Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

21.9% of Venture Life Group shares are held by institutional investors. Comparatively, 0.3% of Beximco Pharmaceuticals shares are held by institutional investors. 7.5% of Venture Life Group shares are held by insiders. Comparatively, 4.2% of Beximco Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Beximco Pharmaceuticals beats Venture Life Group on 7 of the 13 factors compared between the two stocks.

How does Venture Life Group compare to Animalcare Group?

Animalcare Group (LON:ANCR) and Venture Life Group (LON:VLG) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Venture Life Group has a net margin of 17.42% compared to Animalcare Group's net margin of 5.70%. Venture Life Group's return on equity of 7.82% beat Animalcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Animalcare Group5.70% 4.46% 2.97%
Venture Life Group 17.42%7.82%1.56%

In the previous week, Venture Life Group had 1 more articles in the media than Animalcare Group. MarketBeat recorded 1 mentions for Venture Life Group and 0 mentions for Animalcare Group. Venture Life Group's average media sentiment score of 1.11 beat Animalcare Group's score of 0.00 indicating that Venture Life Group is being referred to more favorably in the news media.

Company Overall Sentiment
Animalcare Group Neutral
Venture Life Group Positive

14.3% of Animalcare Group shares are held by institutional investors. Comparatively, 21.9% of Venture Life Group shares are held by institutional investors. 30.1% of Animalcare Group shares are held by insiders. Comparatively, 7.5% of Venture Life Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Animalcare Group has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Animalcare Group£89.11M2.60£36.55M£7.3045.89
Venture Life Group£35.17M2.36£747.21K£4.3715.79

Animalcare Group has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market. Comparatively, Venture Life Group has a beta of 0.234, meaning that its share price is 77% less volatile than the broader market.

Summary

Animalcare Group beats Venture Life Group on 8 of the 13 factors compared between the two stocks.

How does Venture Life Group compare to Bioventix?

Bioventix (LON:BVXP) and Venture Life Group (LON:VLG) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

Bioventix has higher earnings, but lower revenue than Venture Life Group. Bioventix is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bioventix£12.54M6.15£8.12M£140.5210.51
Venture Life Group£35.17M2.36£747.21K£4.3715.79

Bioventix has a beta of 0.555, meaning that its stock price is 45% less volatile than the broader market. Comparatively, Venture Life Group has a beta of 0.234, meaning that its stock price is 77% less volatile than the broader market.

Bioventix has a net margin of 59.30% compared to Venture Life Group's net margin of 17.42%. Bioventix's return on equity of 65.83% beat Venture Life Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Bioventix59.30% 65.83% 54.07%
Venture Life Group 17.42%7.82%1.56%

20.6% of Bioventix shares are owned by institutional investors. Comparatively, 21.9% of Venture Life Group shares are owned by institutional investors. 6.2% of Bioventix shares are owned by insiders. Comparatively, 7.5% of Venture Life Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Bioventix and Bioventix both had 1 articles in the media. Venture Life Group's average media sentiment score of 1.11 beat Bioventix's score of 0.75 indicating that Venture Life Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bioventix
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Venture Life Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Bioventix beats Venture Life Group on 7 of the 12 factors compared between the two stocks.

How does Venture Life Group compare to Open Orphan?

Venture Life Group (LON:VLG) and Open Orphan (LON:ORPH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

21.9% of Venture Life Group shares are held by institutional investors. 7.5% of Venture Life Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Venture Life Group has higher revenue and earnings than Open Orphan.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.36£747.21K£4.3715.79
Open Orphan£34.71M0.00N/AN/AN/A

Venture Life Group has a net margin of 17.42% compared to Open Orphan's net margin of 0.00%. Venture Life Group's return on equity of 7.82% beat Open Orphan's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
Open Orphan N/A N/A N/A

In the previous week, Venture Life Group and Venture Life Group both had 1 articles in the media. Venture Life Group's average media sentiment score of 1.11 beat Open Orphan's score of 0.00 indicating that Venture Life Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Venture Life Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Open Orphan
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Venture Life Group beats Open Orphan on 8 of the 8 factors compared between the two stocks.

How does Venture Life Group compare to ECO Animal Health Group?

Venture Life Group (LON:VLG) and ECO Animal Health Group (LON:EAH) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

In the previous week, Venture Life Group and Venture Life Group both had 1 articles in the media. Venture Life Group's average media sentiment score of 1.11 beat ECO Animal Health Group's score of 0.46 indicating that Venture Life Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Venture Life Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ECO Animal Health Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

21.9% of Venture Life Group shares are owned by institutional investors. Comparatively, 40.6% of ECO Animal Health Group shares are owned by institutional investors. 7.5% of Venture Life Group shares are owned by company insiders. Comparatively, 11.3% of ECO Animal Health Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

ECO Animal Health Group has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.36£747.21K£4.3715.79
ECO Animal Health Group£87.53M0.71£1.05M£3.1529.76

Venture Life Group has a beta of 0.234, suggesting that its share price is 77% less volatile than the broader market. Comparatively, ECO Animal Health Group has a beta of 0.701, suggesting that its share price is 30% less volatile than the broader market.

ECO Animal Health Group has a consensus price target of GBX 160, indicating a potential upside of 70.67%. Given ECO Animal Health Group's stronger consensus rating and higher possible upside, analysts clearly believe ECO Animal Health Group is more favorable than Venture Life Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Venture Life Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Venture Life Group has a net margin of 17.42% compared to ECO Animal Health Group's net margin of 2.50%. Venture Life Group's return on equity of 7.82% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
ECO Animal Health Group 2.50%2.55%2.14%

Summary

ECO Animal Health Group beats Venture Life Group on 10 of the 15 factors compared between the two stocks.

Get Venture Life Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VLG vs. The Competition

MetricVenture Life GroupPharmaceuticals IndustryHealthcare SectorLON Exchange
Market Cap£82.83M£12.42B£7.21B£2.87B
Dividend Yield0.09%2.63%2.56%6.26%
P/E Ratio15.79789.61272.86366.92
Price / Sales2.36952.99701.6990,001.87
Price / Cash6.4089.5077.7127.89
Price / Book1.1710.4110.376.33
Net Income£747.21K£2.83B£3.49B£5.89B
7 Day Performance4.04%-1.53%-0.76%-0.36%
1 Month Performance1.85%0.78%-0.39%-0.68%
1 Year Performance23.21%3.91%18.93%19.86%

Venture Life Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VLG
Venture Life Group
N/AGBX 69
+0.7%
N/A+21.1%£82.83M£35.17M15.79165
BXP
Beximco Pharmaceuticals
N/AGBX 63.25
flat
N/A+26.6%£282.17M£53.93B0.035,500
ANCR
Animalcare Group
N/AGBX 335
flat
N/AN/A£231.30M£89.11M45.89220
BVXP
Bioventix
N/AGBX 1,672
+0.7%
N/A-40.9%£87.36M£12.54M11.9012
ORPH
Open Orphan
N/AN/AN/AN/A£67.09M£34.71MN/A179

Related Companies and Tools


This page (LON:VLG) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners